{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:21:38Z","timestamp":1787235698387,"version":"build-2736575974"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2018,7,15]],"date-time":"2018-07-15T00:00:00Z","timestamp":1531612800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Felix and Ruth Zandman Foundation"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,7,15]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:p>The role of helminth treatment in autoimmune diseases is growing constantly. Systemic lupus erythematosus (SLE) is a multi-system autoimmune disease with challenging treatment options. Tuftsin\u2013phosphorylcholine (TPC) is a novel helminth-based compound that modulates the host immune network. This study was conducted to evaluate the potential value of TPC in ameliorating lupus nephritis in a murine model and specifically to compare the efficacy of TPC to the existing first-line therapy for SLE: corticosteroids (methylprednisolone). Lupus-prone NZBxW\/F1mice were treated with TPC (5\u00a0\u00b5g\/mouse), methylprednisolone (MP; 5\u00a0mg\/body weight) or phosphate-buffered saline (PBS) (control) three times per week once glomerulonephritis, defined as proteinuria of grade\u00a0&amp;gt;\u00a0100\u00a0mg\/dl, was established. Levels of anti-dsDNA autoantibodies were evaluated by enzyme-linked immunosorbent assay (ELISA), splenic cytokines were measured in vitro and the kidney microscopy was analysed following staining. TPC and MP treatments improved lupus nephritis significantly and prolonged survival in NZBxW\/F1 mice. TPC-treated mice showed a significantly decreased level of proteinuria (P\u00a0&amp;lt;\u00a00\u00b7001) and anti-dsDNA antibodies (P\u00a0&amp;lt;\u00a00\u00b7001) compared to PBS-treated mice. Moreover, TPC and MP inhibited the production of the proinflammatory cytokines interferon IFN-\u03b3, interleukin IL-1\u03b2 and IL-6 (P\u00a0&amp;lt;\u00a00\u00b7001) and enhanced expression of the anti-inflammatory cytokine IL-10 (P\u00a0&amp;lt;\u00a00\u00b7001). Finally, microscopy analysis of the kidneys demonstrated that TPC-treated mice maintained normal structure equally to MP-treated mice. These data indicate that the small molecule named TPC hinders lupus development in genetically lupus-prone mice equally to methylprednisolone in most of the cases. Hence, TCP may be employed as a therapeutic potential for lupus nephritis.<\/jats:p>","DOI":"10.1111\/cei.13137","type":"journal-article","created":{"date-parts":[[2018,4,26]],"date-time":"2018-04-26T12:04:49Z","timestamp":1524744289000},"page":"160-166","source":"Crossref","is-referenced-by-count":20,"title":["Tuftsin\u2013phosphorylcholine (TPC) equally effective to methylprednisolone in ameliorating lupus nephritis in a mice model"],"prefix":"10.1093","volume":"193","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4366-5438","authenticated-orcid":false,"given":"A","family":"Shemer","sequence":"first","affiliation":[{"name":"Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel"},{"name":"Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Kivity","sequence":"additional","affiliation":[{"name":"Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel"},{"name":"Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O","family":"Shovman","sequence":"additional","affiliation":[{"name":"Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel"},{"name":"Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Bashi","sequence":"additional","affiliation":[{"name":"Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel"},{"name":"Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O","family":"Perry","sequence":"additional","affiliation":[{"name":"Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Watad","sequence":"additional","affiliation":[{"name":"Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel"},{"name":"Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Israel"},{"name":"Department of Medicine B, Sheba Medical Center, Tel Hashomer, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Ben-Ami Shor","sequence":"additional","affiliation":[{"name":"Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel"},{"name":"Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Volkov","sequence":"additional","affiliation":[{"name":"Institute of Pathology, Sheba Medical Center, Tel Hashomer, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Barshack","sequence":"additional","affiliation":[{"name":"Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel"},{"name":"Institute of Pathology, Sheba Medical Center, Tel Hashomer, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N L","family":"Bragazzi","sequence":"additional","affiliation":[{"name":"Department of Health Sciences (DISSAL), School of Public Health, University of Genoa, Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Krule","sequence":"additional","affiliation":[{"name":"Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel"},{"name":"Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Fridkin","sequence":"additional","affiliation":[{"name":"Department of Organic Chemistry, The Weizmann Institute of Sciences, Rehovot, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Amital","sequence":"additional","affiliation":[{"name":"Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel"},{"name":"Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Israel"},{"name":"Department of Medicine B, Sheba Medical Center, Tel Hashomer, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Blank","sequence":"additional","affiliation":[{"name":"Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel"},{"name":"Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0185-9637","authenticated-orcid":false,"given":"Y","family":"Shoenfeld","sequence":"additional","affiliation":[{"name":"Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel"},{"name":"Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Israel"},{"name":"Incumbent of the Laura Schwarz-Kipp Chair for Research of Autoimmune Diseases, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,7,15]]},"reference":[{"key":"2021120808391538700_cei13137-bib-0001","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1136\/bmj.299.6710.1259","article-title":"Hay fever, hygiene, and household size","volume":"299","author":"Strachan","year":"1989","journal-title":"BMJ"},{"key":"2021120808391538700_cei13137-bib-0002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2010.04139.x","article-title":"The \u2018hygiene hypothesis\u2019 for autoimmune and allergic diseases: an update","volume":"160","author":"Okada","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"2021120808391538700_cei13137-bib-0003","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1056\/NEJMra020100","article-title":"The effect of infections on susceptibility to autoimmune and allergic diseases","volume":"347","author":"Bach","year":"2002","journal-title":"N Engl J Med"},{"key":"2021120808391538700_cei13137-bib-0004","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1136\/gut.2004.041749","article-title":"Trichuris suis therapy in Crohn's disease","volume":"54","author":"Summers","year":"2005","journal-title":"Gut"},{"key":"2021120808391538700_cei13137-bib-0005","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1053\/j.gastro.2005.01.005","article-title":"Trichuris suis therapy for active ulcerative colitis: a randomized controlled trial","volume":"128","author":"Summers","year":"2005","journal-title":"Gastroenterology"},{"key":"2021120808391538700_cei13137-bib-0006","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ijpara.2012.12.004","article-title":"Helminth mediated modulation of Type 1 diabetes (T1D)","volume":"43","author":"Zaccone","year":"2013","journal-title":"Int J Parasitol"},{"key":"2021120808391538700_cei13137-bib-0007","doi-asserted-by":"publisher","DOI":"10.1177\/1352458517736377","article-title":"Safety and efficacy of helminth treatment in relapsing-remitting multiple sclerosis: results of the HINT 2 clinical trial","author":"Fleming","year":"2017","journal-title":"Mult Scler J"},{"key":"2021120808391538700_cei13137-bib-0008","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1017\/S0022149X11000460","article-title":"Immune monitoring of Trichuris suis egg therapy in multiple sclerosis patients","volume":"86","author":"Benzel","year":"2012","journal-title":"J Helminthol"},{"key":"2021120808391538700_cei13137-bib-0009","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1136\/ard.2007.073502","article-title":"The phosphorycholine moiety of the filarial nematode immunomodulator ES-62 is responsible for its anti-inflammatory action in arthritis","volume":"67","author":"Harnett","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"2021120808391538700_cei13137-bib-0010","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1177\/0961203309345735","article-title":"Parasitic infection and autoimmunity","volume":"18","author":"Zandman-Goddard","year":"2009","journal-title":"Lupus"},{"key":"2021120808391538700_cei13137-bib-0011","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/228672a0","article-title":"Tuftsin\u2019: a natural phagocytosis stimulating peptide","volume":"228","author":"Najjar","year":"1970","journal-title":"Nature"},{"key":"2021120808391538700_cei13137-bib-0012","doi-asserted-by":"crossref","first-page":"3711","DOI":"10.2174\/0929867324666170725140826","article-title":"Tuftsin \u2013 properties and analogs","volume":"24","author":"Siebert","year":"2017","journal-title":"Curr Med Chem"},{"key":"2021120808391538700_cei13137-bib-0013","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1056\/NEJMra1100359","article-title":"Systemic lupus erythematosus","volume":"365","author":"Tsokos","year":"2011","journal-title":"N Engl J Med"},{"key":"2021120808391538700_cei13137-bib-0014","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1016\/S0140-6736(14)60128-8","article-title":"Systemic lupus erythematosus","volume":"384","author":"Lisnevskaia","year":"2014","journal-title":"Lancet"},{"key":"2021120808391538700_cei13137-bib-0015","first-page":"2595","article-title":"A comparison of the quality of life of patients with systemic lupus erythematosus with and without endstage renal disease","volume":"26","author":"Vu","year":"1999","journal-title":"J Rheumatol"},{"key":"2021120808391538700_cei13137-bib-0016","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S0140-6736(13)60889-2","article-title":"Systemic lupus erythematosus and other autoimmune rheumatic diseases: challenges to treatment","volume":"382","author":"Murphy","year":"2013","journal-title":"Lancet"},{"key":"2021120808391538700_cei13137-bib-0017","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/0002-9343(94)90151-1","article-title":"Effect of prednisone and hydroxychloroquine on coronary artery disease risk factors in systemic lupus erythematosus: a longitudinal data analysis","volume":"96","author":"Petri","year":"1994","journal-title":"Am J Med"},{"key":"2021120808391538700_cei13137-bib-0018","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jaut.2014.11.001","article-title":"Phosphorylcholine\u2013tuftsin compound prevents development of dextransulfate-sodium-salt induced murine colitis: implications for the treatment of human inflammatory bowel disease","volume":"56","author":"Ben-Ami Shor","year":"2015","journal-title":"J Autoimmun"},{"key":"2021120808391538700_cei13137-bib-0019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2015.03.001","article-title":"Successful modulation of murine lupus nephritis with tuftsin\u2013phosphorylcholine","volume":"59","author":"Bashi","year":"2015","journal-title":"J Autoimmun"},{"key":"2021120808391538700_cei13137-bib-0020","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/cei.12745","article-title":"Novel therapeutic compound tuftsin\u2013phosphorylcholine attenuates collagen-induced arthritis","volume":"184","author":"Bashi","year":"2016","journal-title":"Clin Exp Immunol"},{"key":"2021120808391538700_cei13137-bib-0021","doi-asserted-by":"crossref","first-page":"6527","DOI":"10.1016\/j.vaccine.2012.08.054","article-title":"Enhanced immune response induced by a potential influenza A vaccine based on branched M2e polypeptides linked to tuftsin","volume":"30","author":"Liu","year":"2012","journal-title":"Vaccine"},{"key":"2021120808391538700_cei13137-bib-0022","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1056\/NEJM198302243080802","article-title":"Polyspecificity of monoclonal lupus autoantibodies produced by human\u2013human hybridomas","volume":"308","author":"Shoenfeld","year":"1983","journal-title":"N Engl J Med"},{"key":"2021120808391538700_cei13137-bib-0023","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1093\/intimm\/dxf099","article-title":"Efficacy of IVIG affinity-purified anti-double-stranded DNA anti-idiotypic antibodies in the treatment of an experimental murine model of systemic lupus erythematosus","volume":"14","author":"Shoenfeld","year":"2002","journal-title":"Int Immunol"},{"key":"2021120808391538700_cei13137-bib-0024","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1210\/er.2002-0006","article-title":"The interplay between the glucocorticoid receptor and nuclear factor-kappaB or activator protein-1: molecular mechanisms for gene repression","volume":"24","author":"De Bosscher","year":"2003","journal-title":"Endocr Rev"},{"key":"2021120808391538700_cei13137-bib-0025","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.mce.2010.04.005","article-title":"The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights","volume":"335","author":"Coutinho","year":"2011","journal-title":"Mol Cell Endocrinol"},{"key":"2021120808391538700_cei13137-bib-0026","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1172\/JCI106385","article-title":"The effect of hydrocortisone on immunoglobulin metabolism","volume":"49","author":"Levy","year":"1970","journal-title":"J Clin Invest"},{"key":"2021120808391538700_cei13137-bib-0027","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1172\/JCI109017","article-title":"Glucocorticoids administered in vivo inhibit human suppressor T lymphocyte function and diminish B lymphocyte responsiveness in in vitro immunoglobulin synthesis","volume":"61","author":"Saxon","year":"1978","journal-title":"J Clin Invest"},{"key":"2021120808391538700_cei13137-bib-0028","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/0005-2795(73)90025-1","article-title":"The chemical synthesis of the phagocytosis-stimulating tetrapeptide tuftsin (Thr-Lys-Pro-Arg) and its biological properties","volume":"310","author":"Nishioka","year":"1973","journal-title":"Biochim Biophys Acta"},{"key":"2021120808391538700_cei13137-bib-0029","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0196-9781(99)00019-4","article-title":"Tuftsin: on the 30-year anniversary of Victor Najjar's discovery","volume":"20","author":"Siemion","year":"1999","journal-title":"Peptides"},{"key":"2021120808391538700_cei13137-bib-0030","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0162-3109(84)90034-1","article-title":"Stimulating effect of tuftsin and its analogues on the defective monocyte chemotaxis in systemic lupus erythematosus","volume":"7","author":"Luk\u00e1cs","year":"1984","journal-title":"Immunopharmacology"},{"key":"2021120808391538700_cei13137-bib-0031","doi-asserted-by":"crossref","first-page":"7454","DOI":"10.4049\/jimmunol.173.12.7454","article-title":"Helminth antigens modulate TLR-initiated dendritic cell activation","volume":"173","author":"Kane","year":"2004","journal-title":"J Immunol"},{"key":"2021120808391538700_cei13137-bib-0032","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/nri3063","article-title":"Highlights of 10 years of immunology in Nature Reviews Immunology","volume":"11","author":"Medzhitov","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"2021120808391538700_cei13137-bib-0033","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.cellimm.2011.10.007","article-title":"Deficiency in TLR2 but not in TLR4 impairs dendritic cells derived IL-10 responses to schistosome antigens","volume":"272","author":"Gao","year":"2012","journal-title":"Cell Immunol"},{"key":"2021120808391538700_cei13137-bib-0034","doi-asserted-by":"crossref","first-page":"24748","DOI":"10.1074\/jbc.M800352200","article-title":"Oxidized phospholipid inhibition of Toll-like receptor (TLR) signaling is restricted to TLR2 and TLR4: roles for CD14, LPS-binding protein, and MD2 as targets for specificity of inhibition","volume":"283","author":"Erridge","year":"2008","journal-title":"J Biol Chem"},{"key":"2021120808391538700_cei13137-bib-0035","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1177\/0961203308090029","article-title":"Current treatment of lupus nephritis","volume":"17","author":"Houssiau","year":"2008","journal-title":"Lupus"},{"key":"2021120808391538700_cei13137-bib-0036","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1002\/art.30613","article-title":"A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus","volume":"63","author":"Furie","year":"2011","journal-title":"Arthritis Rheum"},{"key":"2021120808391538700_cei13137-bib-0037","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1093\/rheumatology\/keu412","article-title":"Birmingham SLE cohort: outcomes of a large inception cohort followed for up to 21 years","volume":"54","author":"Yee","year":"2015","journal-title":"Rheumatology (Oxf)"},{"key":"2021120808391538700_cei13137-bib-0038","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/art.34359","article-title":"Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the lupus nephritis assessment with rituximab study","volume":"64","author":"Rovin","year":"2012","journal-title":"Arthritis Rheum"},{"key":"2021120808391538700_cei13137-bib-0039","doi-asserted-by":"crossref","first-page":"e34933","DOI":"10.1371\/journal.pone.0034933","article-title":"Tuftsin promotes an anti-inflammatory switch and attenuates symptoms in experimental autoimmune encephalomyelitis","volume":"7","author":"Wu","year":"2012","journal-title":"PLOS ONE"},{"key":"2021120808391538700_cei13137-bib-0040","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1365-2249.2009.04064.x","article-title":"The therapeutic potential of the filarial nematode-derived immunodulator, ES-62 in inflammatory disease","volume":"159","author":"Harnett","year":"2010","journal-title":"Clin Exp Immunol"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fcei.13137","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/193\/2\/160\/41645546\/cei13137.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/193\/2\/160\/41645546\/cei13137.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T11:28:17Z","timestamp":1641036497000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/193\/2\/160\/6411927"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,15]]},"references-count":40,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,7,15]]},"published-print":{"date-parts":[[2018,7,15]]}},"URL":"https:\/\/doi.org\/10.1111\/cei.13137","relation":{},"ISSN":["0009-9104","1365-2249"],"issn-type":[{"value":"0009-9104","type":"print"},{"value":"1365-2249","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,8]]},"published":{"date-parts":[[2018,7,15]]}}}